Immuneering Corporation (IMRX) Reports In-Line Q2 EPS
Tweet
Share
E-mail
Get Alerts IMRX Hot Sheet
Join SI Premium – FREE
Immuneering Corporation (NASDAQ: IMRX) reported Q2 EPS of ($0.27), in-line with the analyst estimate of ($0.27).
For earnings history and earnings-related data on Immuneering Corporation (IMRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Erste Group Upgrades salesforce.com (CRM) to Buy
- Erste Group Upgrades Abbvie (ABBV) to Buy
- Ball Corp (BALL) PT Raised to $78 at Truist Securities
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
